Etodolac



Indications and Reactions:

Role Indications Reactions
Primary
Pain 22.7%
Rheumatoid Arthritis 11.9%
Arthritis 9.7%
Back Pain 9.7%
Osteoarthritis 6.7%
Product Used For Unknown Indication 6.3%
Arthralgia 5.2%
Hypertension 4.5%
Thrombosis Prophylaxis 4.5%
Cancer Pain 2.2%
Musculoskeletal Pain 2.2%
Prostate Cancer 2.2%
Drug Use For Unknown Indication 1.9%
Spinal Osteoarthritis 1.9%
Cachexia 1.5%
Insomnia 1.5%
Myocardial Infarction 1.5%
Neck Pain 1.5%
Pain In Extremity 1.5%
Inflammation 1.1%
Gastrointestinal Haemorrhage 12.4%
Renal Failure Acute 12.4%
Rectal Haemorrhage 9.7%
Vomiting 8.0%
Gastric Haemorrhage 7.1%
Completed Suicide 5.3%
Urticaria 5.3%
Colitis Microscopic 4.4%
Death 3.5%
Duodenal Ulcer Perforation 3.5%
Pruritus 3.5%
Toxic Epidermal Necrolysis 3.5%
Diarrhoea 2.7%
Haematemesis 2.7%
Hyperkalaemia 2.7%
Oedema Peripheral 2.7%
Pain 2.7%
Pneumothorax 2.7%
Renal Failure 2.7%
Respiratory Arrest 2.7%
Secondary
Headache 15.0%
Rheumatoid Arthritis 13.4%
Product Used For Unknown Indication 12.4%
Drug Use For Unknown Indication 9.0%
Bone Disorder 7.5%
Respiratory Disorder 7.5%
Pain 6.6%
Prophylaxis 5.5%
Multiple Myeloma 3.8%
Hypertension 3.3%
Back Pain 2.7%
Metastatic Renal Cell Carcinoma 2.7%
Thrombosis Prophylaxis 2.6%
Arthritis 1.2%
Cachexia 1.2%
Cancer Pain 1.2%
Constipation 1.2%
Insomnia 1.2%
Neck Pain 1.1%
Osteoporosis 1.1%
Toxicity To Various Agents 11.2%
Completed Suicide 10.3%
Death 7.5%
Drug Hypersensitivity 7.5%
Stomatitis 5.6%
Pain In Extremity 4.7%
Pyrexia 4.7%
Respiratory Arrest 4.7%
White Blood Cell Count Increased 4.7%
Anaemia 3.7%
Atrial Fibrillation 3.7%
Drug Toxicity 3.7%
Interstitial Lung Disease 3.7%
Pleural Effusion 3.7%
Renal Failure 3.7%
Sepsis 3.7%
Somnolence 3.7%
White Blood Cell Count Decreased 3.7%
Aplastic Anaemia 2.8%
Cardio-respiratory Arrest 2.8%
Concomitant
Rheumatoid Arthritis 26.9%
Product Used For Unknown Indication 18.3%
Drug Use For Unknown Indication 12.7%
Prophylaxis 6.8%
Pain 5.8%
Hypertension 4.7%
Depression 3.0%
Osteoporosis 2.7%
Insomnia 2.4%
Anxiety 1.9%
Multiple Myeloma 1.9%
Metastatic Renal Cell Carcinoma 1.7%
Arthritis 1.5%
Breast Cancer Metastatic 1.5%
Gastrooesophageal Reflux Disease 1.5%
Renal Cell Carcinoma 1.4%
Breast Cancer 1.4%
Gastritis 1.4%
Asthma 1.3%
Psoriatic Arthropathy 1.2%
Vomiting 12.8%
Pneumonia 7.2%
Rash 5.9%
Pain 5.8%
Weight Decreased 5.8%
Weight Increased 5.8%
Pyrexia 5.6%
Nausea 5.2%
White Blood Cell Count Increased 5.1%
Pulmonary Embolism 4.7%
Type 2 Diabetes Mellitus 4.7%
Urinary Tract Infection 4.5%
Drug Ineffective 3.8%
Myocardial Infarction 3.5%
Rheumatoid Arthritis 3.5%
White Blood Cell Count Decreased 3.5%
Pneumocystis Jiroveci Pneumonia 3.3%
Headache 3.1%
Hepatic Function Abnormal 3.1%
Wound Treatment 3.0%